Clinical trial
A Randomized Double Blind Controlled Trial of Non-invasive Preimplantation Genetic Testing for Aneuploidy in Women With Recurrent Pregnancy Loss
NCT05685147 is registered in ClinicalTrials.gov with Queen Mary Hospital, Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double Blind Controlled Trial of Non-invasive Preimplantation Genetic Testing for Aneuploidy in Women With Recurrent Pregnancy Loss
- Lead sponsor
- Queen Mary Hospital, Hong Kong
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2023
- Completion date
- February 27, 2026
- Enrollment
- 152 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.